R&D / portfolio
Parallel assessment of targets, clinical programs, reference products, patents and competing filings.
Xanda Data is built on structured pharmaceutical information for R&D, registration, BD and commercial teams — connecting products, companies, clinical, review, access and sales signals so complex facts become decisions faster.
The core databases from the original homepage, reorganized around real work — not a tool catalog.
Acceptance numbers, review progress and filing landscape
Approvals, labels and linked access data
All-channel, hospital sample and competitor trends
Awards, listing, VBP and price execution
A single information structure across systems, so teams can filter, compare and track from one confirmed lead.
The registration front end brings together CDE acceptance, review, generic consistency (BE) and DMF/excipient/packaging filings so R&D and RA teams can confirm status and competitive position quickly.
China registration acceptance records
A verifiable, traceable judgment chain for cross-team, cross-source questions in R&D and commercialization.
Parallel assessment of targets, clinical programs, reference products, patents and competing filings.
Acceptance-number progress, review updates, DMF/excipient filings and generic-consistency tracking.
Labels, NRDL, VBP, provincial listing and price execution — linked as one story.
Sales trends, competitor substitution, regional channels and deal value — in multiple dimensions.
Professional-mode and natural-language entry points for large-scale search, linkage, analysis and presentation-ready output.
Visit DrugSEABuilt for mobile work: approvals, tenders, sales, registration and clinical — plus subscriptions on key products and companies.
See the mobile productFrom the Xanda Drug Express monthly brief to FTO, competitor sales and channel maps — rigorous research for non-standard questions.
See research casesWhether you need database access, subscriptions, or a study around one product or market, an advisor will match the right path.